Basics ANI Pharmaceuticals, Inc. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. IPO Date: July 18, 2013 Sector: Healthcare Industry: Pharma Market Cap: $1.49B Activated in VL: True Average Daily Range Avg Daily Range: $0.91 | 2.07% Avg Daily Range (30 D): $1.16 | 1.77% Avg Daily Range (90 D): $0.94 | 1.54% Institutional Daily Volume Avg Daily Volume: .14M Avg Daily Volume (30 D): .27M Avg Daily Volume (90 D): .2M Trade Size Avg Trade Size (Sh.): 71 Avg Trade Size (Sh.) (30 D): 42 Avg Trade Size (Sh.) (90 D): 41 Institutional Trades Total Inst.Trades: 1,907 Avg Inst. Trade: $1.8M Avg Inst. Trade (30 D): $2.99M Avg Inst. Trade (90 D): $2.69M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.08M Avg Closing Trade (30 D): $3.96M Avg Closing Trade (90 D): $3.44M Avg Closing Volume: 36.95K         News Feb 28, 2025 @ 3:37 PM ANI Pharmaceuticals Expects Strong Start To 2025, ... Source: Vandana Singh Oct 30, 2024 @ 9:00 PM ANI Pharmaceuticals to Discuss Third Quarter 2024 ... Source: N/A Oct 18, 2024 @ 6:38 PM Avadel Obtains FDA Nod for Label Expansion Of Narc... Source: Zacks Oct 17, 2024 @ 5:44 PM Alnylam Stock Up on Cardiomyopathy Drug Regulatory... Source: Zacks Sep 24, 2024 @ 7:08 PM BHVN Stock Up as Rare Neurological Disease Study M... Source: Zacks Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.04 $-.55 $-1.04 Diluted EPS $-1.04 $-.55 $-1.04 Revenue $ 614.38M $ 190.57M $ 614.38M Gross Profit $ $ $ Net Income / Loss $ -18.52M $ -10.28M $ -18.52M Operating Income / Loss $ .58M $ -4.38M $ .58M Cost of Revenue $ $ $ Net Cash Flow $ -76.23M $ -.12M $ -76.23M PE Ratio     Splits Jul 18, 2013:   6:1 Jun 04, 2012:   6:1 Jun 03, 2002:   10:1